Back to ROYCE & ASSOCIATES LP ROYCE & ASSOCIATES LP

APYXAPYX
Showing 8 of 30 quarters

Position history for ROYCE & ASSOCIATES LPROYCE & ASSOCIATES LP's holdings in APYX MEDICAL CORPORATION

ROYCE & ASSOCIATES LP holds 3.3M shares of APYX (APYX MEDICAL CORPORATION), worth $14.7M as of 2026-Q2. The position was increased (+25.4% shares). APYX represents 0.1% of ROYCE & ASSOCIATES LP's portfolio.

Current Value

$14.7M

Current Shares

3.3M

Total Value Change

+$11.5M

Total Shares Change

+691,574

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.3M
+25.4%
$14.7M0.1%$4.49
41
2026-Q1
Increased
2.6M
+6.9%
$9.6M0.1%$3.17
30
2025-Q4
Decreased
2.4M
-1.3%
$8.6M0.1%$3.44
0
2025-Q3
Increased
2.5M
+1.4%
$5.3M0.1%$2.18
27
2025-Q2
Decreased
2.4M
-3.4%
$5.5M0.1%$2.16
0
2025-Q1
Decreased
2.5M
-3.4%
$3.5M0.0%$1.30
0
2024-Q4
Increased
2.6M
+1.3%
$4.1M0.0%$1.58
27
2024-Q3
Increased
2.6M
+3.4%
$3.2M0.0%$1.20
27

Other major holders of APYX: Steward Partners Investment Advisory, LLC, BNP PARIBAS FINANCIAL MARKETS, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used